Stockscreener 앱 받기
11.48
3.14%
0.35
전일 마감가:
$11.13
열려 있는:
$11.13
하루 거래량:
115.93K
Relative Volume:
2.67
시가총액:
$73.66M
수익:
$169.43M
순이익/손실:
$-186.01M
주가수익비율:
-5.6832
EPS:
-2.02
순현금흐름:
$70.07M
1주 성능:
+24.92%
1개월 성능:
+4.35%
6개월 성능:
+12.53%
1년 성능:
-4.87%
1일 변동 폭
$10.70
$11.62
1주일 범위
$9.1947
$11.62
52주 변동 폭
$7.7055
$15.15
애서티오 홀딩스 Stock (ASRT) Company Profile
명칭
Assertio Holdings Inc
전화
(224) 419-7106
주소
100 S. SAUNDERS ROAD, LAKE FOREST, IL
ASRT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
11.48 | 71.42M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
애서티오 홀딩스 Stock (ASRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-26 | 개시 | Maxim Group | Buy |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2022-11-07 | 개시 | Lake Street | Buy |
| 2018-11-30 | 다운그레이드 | Mizuho | Buy → Neutral |
애서티오 홀딩스 주식(ASRT)의 최신 뉴스
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet - Your Wyoming Link
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Assertio regains Nasdaq compliance after bid price recovery - MSN
Assertio regains nasdaq compliance after successful reverse split By Investing.com - Investing.com Nigeria
Short Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Decreases By 92.8% - MarketBeat
Assertio Therapeutics announces 1-for-15 reverse stock split - MSN
Assertio regains compliance with Nasdaq minimum bid price requirement - Investing.com
Assertio regains nasdaq compliance after successful reverse split - Investing.com
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - The Joplin Globe
This company just cleared the bar to keep its Nasdaq listing after a split - Stock Titan
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story - Yahoo Finance
Assertio Reports Positive Clinical Trial Results for Rolvedon with Same-Day Dosing - Intellectia AI
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - The Joplin Globe
Same-day cancer drug shot shows similar results to next-day dosing in trial - Stock Titan
Why Assertio Holdings Inc. stock is trending among retail traders2025 Investor Takeaways & AI Forecast Swing Trade Picks - Улправда
Why Assertio Holdings Inc. stock remains a top recommendationForecast Cut & Real-Time Sentiment Analysis - Улправда
What momentum indicators show for Assertio Holdings Inc. stockJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
FY2025 EPS Estimates for Assertio Raised by HC Wainwright - Defense World
FY2025 EPS Estimates for Assertio Increased by HC Wainwright - MarketBeat
HC Wainwright Forecasts Assertio’s Q4 Earnings (NASDAQ:ASRT) - Defense World
What is HC Wainwright's Forecast for Assertio Q4 Earnings? - MarketBeat
Support Test: Can Assertio Holdings Inc stock deliver 10 annual returnsMarket Performance Recap & Weekly Watchlist of Top Performers - moha.gov.vn
H.C. Wainwright raises Assertio stock price target to $35 following reverse split - Investing.com Canada
H.C. Wainwright raises Assertio stock price target to $35 following reverse split By Investing.com - Investing.com South Africa
Assertio (NASDAQ:ASRT) Upgraded at Zacks Research - Defense World
Analysts’ Top Healthcare Picks: Assertio Therapeutics (ASRT), REPRO-MED Systems (KRMD) - The Globe and Mail
Assertio (NASDAQ:ASRT) Raised to Strong-Buy at Zacks Research - MarketBeat
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - marketscreener.com
Assertio Holdings announces 1-for-15 reverse stock split - MSN
ASSERTIO HOLDINGS INC Financial Disclosures & Filings - TradingView — Track All Markets
Assertio (NASDAQ:ASRT) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business - simplywall.st
Assertio to implement 1-for-15 reverse stock split on Dec 26 - Investing.com Australia
Assertio Holdings, Inc. announces 1-for-15 reverse stock split - marketscreener.com
Assertio to Effect 1-for-15 Reverse Stock Split - marketscreener.com
Assertio Therapeutics Announces 1-for-15 Reverse Stock Split - TipRanks
Assertio to implement 1-for-15 reverse stock split on Dec 26 By Investing.com - Investing.com South Africa
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split - marketscreener.com
Aug Technicals: Will Assertio Holdings Inc. stock see PE expansionInsider Buying & Daily Stock Momentum Reports - Улправда
Pretax income of Assertio Holdings, Inc. – LS:A3CRAA - TradingView — Track All Markets
Can Assertio Holdings Inc. stock resist market sell offsWeekly Stock Recap & Verified Swing Trading Watchlists - Bölüm Sonu Canavarı
Will Assertio Holdings Inc. stock see PE expansionTrend Reversal & Technical Pattern Alert System - Улправда
Should I hold or sell Assertio Holdings Inc. stock in 2025Product Launch & Low Drawdown Investment Ideas - Улправда
Assertio (NASDAQ:ASRT) Trading Down 3.2%Time to Sell? - MarketBeat
애서티오 홀딩스 (ASRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
1.45%
자본화:
|
볼륨(24시간):